David Baker
David Baker is Professor and Institute Leader at the University of Washington, where he also serves as Director at the Institute for Protein Design and UW Medicine’s Institute for Protein Design. He is Co-founder and Lab Head at the University of Washington Institute for Protein Design.
Icosavax, UW IPD Spinout, Raises $100M Series B to Advance Computer-Designed Virus‑Like Particle Vaccines
Seattle biotech Icosavax, a University of Washington Institute for Protein Design spinout, raised $100 million in a Series B to develop computer-designed, virus-like particle vaccines including programs for COVID-19, RSV, and hMPV. The company, backed by investors led by RA Capital and supported by a $10 million Gates Foundation grant, has 17 employees and cites strong preclinical immune responses.
A-Alpha Bio wins $620,472 NSF Phase II SBIR to develop molecular-glue discovery system
Seattle startup A-Alpha Bio received a $620,472 NSF Phase II SBIR grant to develop a system that identifies molecular glues which tag disease-causing proteins for cellular degradation, aiming to target previously 'undruggable' proteins for diseases like Alzheimer’s, cancer and autoimmune disorders.
Takeda buys Seattle startup PvP Biologics for up to $330M, will advance TAK-062 into Phase 2
Japanese pharmaceutical Takeda acquired Seattle biotech PvP Biologics for up to $330 million in late February, taking over its TAK-062 (Kuma062) program and all clinical and manufacturing activities while laying off PvP staff. Takeda plans to run phase 2 trials of the enzyme-based celiac disease treatment that PvP developed after earlier funding of $35 million supported phase 1 work.
Seattle’s A-Alpha Bio Raises $2.8M Seed Round to Advance AlphaSeq Drug Discovery Platform
Seattle startup A-Alpha Bio raised $2.8 million in seed funding to advance its genetically engineered protein analysis platform, AlphaSeq, which accelerates drug candidate evaluation by sorting millions of protein interactions. The round was led by OS Fund and included investors such as Madrona Venture Group and AME Cloud Ventures.
Organizations
See all 4-
Institute for Protein Design Director · current
-
University of Washington Professor / Institute Leader (Institute for Protein Design) · current
-
UW Institute for Protein Design Co-founder and Lab Head, Nobel Laureate · current
